Results: 208

Capítulo 12. Colitis indeterminada
Chapter 12. Indeterminate Colitis

Terapia de inducción acelerada con infliximab en paciente con colitis ulcerosa grave refractaria a corticoides: caso clínico

Rev. méd. Chile; 145 (8), 2017
Acute severe ulcerative colitis (ASUC) is a potentially life-threatening condition that requires early recognition, hospitalization and adequate treatment. Currently, the use of infliximab in ulcerative colitis (UC) is recommended in the case of severe disease refractory to corticosteroids, once that sup...

Evaluation of fecal protein S100A12 in patients with inflammatory bowel disease

BACKGROUND AND OBJECTIVE: The diagnosis and evaluation of inflammatory bowel disease is quite complex. An ideal, noninvasive marker for this disease is quite urgently needed. Fecal S100A12 is a member of the S100 protein family and is secreted by activated neutrophils. We aim to evaluate it as a biomarke...

Efficacy of tacrolimus for induction of remission in patients with moderate-to-severe ulcerative colitis: a systematic review and meta-analysis

Arq. gastroenterol; 54 (2), 2017
ABSTRACT BACKGROUND There is evidence that shows that calcineurin inhibitors may be useful for the treatment of severe ulcerative colitis. However, evidence regarding the efficacy of tacrolimus for remission induction in this setting is scarce. OBJECTIVE To develop a systematic review on the existing...

Body composition in patients with crohn's disease and ulcerative colitis

Arq. gastroenterol; 54 (2), 2017
ABSTRACT BACKGROUND The nutritional status of individuals with inflammatory bowel diseases is directly related to the severity of the disease and is associated with poor prognosis and the deterioration of immune competence. OBJECTIVE To assess the nutritional status and the body composition of outpatie...

Inflammatory bowel disease: outpatient treatment profile

Arq. gastroenterol; 54 (2), 2017
ABSTRACT BACKGROUND Crohn’s disease and ulcerative colitis are the two major forms of inflammatory bowel disease. The incidence and prevalence of both conditions have increased and are progressively increasing. These diseases are frequently recurrent and clinically highly severe. In Brazil, the la...

Eficacia y seguridad de golimumab en pacientes con colitis ulcerativa moderada a severa, refractaria a tratamiento convencional y biológico con infliximab

INTRODUCCIÓN: Antecedentes: El presente dictamen expone la evaluación de tecnologia de la eficacia y seguridad de golimumab en pacientes con colitis ulcerativa moderada o severa, refractaria al tratamiento convencional y biológico con infliximab. Aspectos Generales: La colitis ulcerativa (CU) es la co...

Diagnóstico y manejo de colitis ulcerosa grave: una mirada actualizada

Rev. méd. Chile; 145 (1), 2017
Ulcerative Colitis (UC) is a chronic inflammatory disease involving the colon, with alternating periods of remission and activity. Exacerbations can be severe and associated with complications and mortality. Diagnosis of severe UC is based on clinical, biochemical and endoscopic variables. Patients with ...

Alert for bone alterations and low serum concentrations of vitamin D in patients with intestinal inflammatory disease

Summary Background: Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are characterized by chronic inflammation of the intestine that can reduce the absorption of nutrients such as vitamin D and calcium. Objective: To investigate bone alterations and serum l...